Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2003

View Archived Issues

Antimetastatic effects of a CXCR4 antagonist evaluated in vitro and in vivo in mice

Inhibitex and Texas A&M researchers claim SdrG-targeted antibodies as bacterial vaccines

New CDK inhibitors recently identified at Schering AG

Walter Reed Army Institute scientists prepare and test a novel antimalarial agent

Novel antibacterial carbapenems presented by Wyeth Lederle Japan researchers

Pfizer designs new alpha1L-adrenoceptor antagonists for BPH therapy

GSK team develops new calcitonin agonists with potential in bone disorders

Phase IIb trial of ATL-962 for obesity meets primary endpoint

Positive preliminary findings emerge from phase IIb trial of renzapride for mixed-symptom IBS

Phase III IND filed for interferon alfa lozenges for oral warts in HIV patients

SBIR grant supports GPCR efforts at Novasite

Third-quarter progress at Genzyme

ISTA updates pipeline progress

Quarterly highlights at Karo Bio

Positive data reported on AGT-MI for angiogenic therapy

Sunesis acquires exclusive rights to SPC-595

Orally active PDE5 inhibitor shows potential for use in pulmonary hypertension

Preclinical efficacy of the cannabinoid CB1 receptor antagonist SR-14176A in improving memory

Development and marketing agreement for Ventavis signed for U.S.

Potential role suggested for arginase inhibitors in the treatment of overactive bladder

A novel target described for the therapy of chronic cystitis

Endothelin receptors suggested as potential targets for overactive bladder

Stampidine as a potential nonspermicidal anti-HIV microbicide

Benefits reported for a menotropin/follitropin alfa combination in IVF

Effects of trimegestone/conjugated estrogens in postmenopausal women

Beneficial effects on cholesterol and adiposity for EM-652 in ovariectomized animals

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...